Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Alliance Pharma Plc
Life Sciences
2017: strong operational cashflow
By
Dr Martin Hall
29 Jan 2018
City of London Investment Group
Financials
FUM, profits and dividend all moving on up
By
Dr Brian Moretta
22 Jan 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Avacta Group plc
Life Sciences
Gene delivery collaboration
By
Dr Martin Hall
22 Jan 2018
ValiRx
Life Sciences
VAL401 improves quality of life
18 Jan 2018
Avacta Group plc
Life Sciences
Affimer Drug Conjugates a reality
By
Dr Martin Hall
15 Jan 2018
Alliance Pharma Plc
Life Sciences
Acquisitions to boost growth prospects
By
Dr Martin Hall
11 Jan 2018
Burford Capital
Financials
Continued evidence of growth
By
Dr Brian Moretta
10 Jan 2018
Primary Health Properties
Investment Companies
All the more reason to anticipate stable growth
By
Mike Foster
10 Jan 2018
Diurnal Group Plc
Life Sciences
Alkindi®: On route to Europe
By
Dr Martin Hall
19 Dec 2017
Collagen Solutions Plc
Life Sciences
Targeting long-term sustainable growth
By
Dr Martin Hall
19 Dec 2017
Titon Holdings
Building & Construction
Over the moon
18 Dec 2017
Prev
1
...
22
23
24
25
26
...
30
Next
